Oral progestins achieved a nearly 90% success rate in reducing or stopping heavy menstrual bleeding among adolescent and young adult females with bleeding disorders, according to a study published in the Journal of Adolescent Health. The findings suggest these medications outperformed four other treatment methods evaluated by researchers.
The retrospective study, led by He Huang, MD, of Peking University First Hospital, tracked 121 patients referred to a joint pediatric and adolescent gynecology-pediatric hematology clinic between 2016 and 2023. The cohort included individuals with confirmed bleeding disorders, most frequently von Willebrand disease, which affected 81 patients, and immune thrombocytopenia, which affected 24 patients.
Researchers defined efficacy based on a 90-day reference period. Success was measured by achieving any of four bleeding patterns, ranging from complete amenorrhea to lighter bleeding or infrequent spotting.
Progestins outperform oral contraceptive pills and other modalities
While oral contraceptive pills (OCPs) were the most frequent initial therapy, prescribed to 62.8% of the study group, they were less effective than oral progestins. The study found that 58.7% of patients required two or more different regimens before their menstrual bleeding reached adequate control.
The efficacy rates for the various treatments evaluated in the study are as follows:
| Treatment Modality | Efficacy Rate |
|---|---|
| Oral progestins | 89.8% |
| Levonorgestrel-releasing intrauterine system | 81.5% |
| Oral contraceptive pills (OCPs) | 65.5% |
Oral progestins also showed statistically significant superiority (P < .05) over OCPs, transdermal patches, depot medroxyprogesterone acetate injections, and vaginal rings.
Clinical goals shift toward bleeding reduction over complete cessation
Achieving the total absence of menstruation proved difficult for this patient population. Only 17.4% of the participants achieved complete amenorrhea. Instead, the majority of successful outcomes involved managing the volume and frequency of blood loss.
More than half of the patients (54.5%) reached a state of infrequent spotting or lighter bleeding. Another 14.9% attained spotting or lighter bleeding at a normal frequency, while 13.2% experienced frequent or prolonged spotting or lighter bleeding.
The authors noted that because complete amenorrhea is difficult to achieve in these patients, clinical objectives should focus on meaningful bleeding reduction to support long-term quality of life and patient satisfaction. They suggested that oral progestins should be considered a first-line option for managing heavy menstrual bleeding in this demographic.
Did you know?
For 73.6% of the patients in this study, a diagnosis of a bleeding disorder was only made after the onset of heavy menstrual bleeding.
Incomplete records limit broad application of findings
Heavy menstrual bleeding began within one year of menarche for 79.3% of the participants. The average age at presentation was 14.3 years, with follow-up durations ranging from one to nine years.
The researchers identified certain limitations in the data. Incomplete records regarding specific OCP formulations meant the team could not analyze results by estrogen dose or progestin type. The small number of patients in certain treatment groups may limit how broadly these findings apply to the general population.
Common questions regarding adolescent bleeding disorder treatments
What is the most effective treatment for heavy menstrual bleeding in adolescents with bleeding disorders?
Based on this study, oral progestins demonstrated the highest efficacy rate at 89.8%. This was higher than the 81.5% efficacy rate seen with the levonorgestrel-releasing intrauterine system.
Is it common for patients to stop having periods entirely with these treatments?
No. Complete cessation of menstrual bleeding, or amenorrhea, was achieved in only 17.4% of the patients studied. Most patients achieved lighter bleeding or infrequent spotting instead.
How often is a bleeding disorder diagnosed in relation to heavy periods?
In this study, 73.6% of patients did not receive a diagnosis of a bleeding disorder until after their heavy menstrual bleeding had already started.
The study was published online on October 21, 2026, in the Journal of Adolescent Health.